168 related articles for article (PubMed ID: 9326762)
1. Tetrandrine potently inhibits herpes simplex virus type-1-induced keratitis in BALB/c mice.
Hu S; Dutt J; Zhao T; Foster CS
Ocul Immunol Inflamm; 1997 Sep; 5(3):173-80. PubMed ID: 9326762
[TBL] [Abstract][Full Text] [Related]
2. 6-Thioguanine Inhibits Herpes Simplex Virus 1 Infection of Eyes.
Chen D; Liu Y; Zhang F; You Q; Ma W; Wu J; Wu Z
Microbiol Spectr; 2021 Dec; 9(3):e0064621. PubMed ID: 34730435
[TBL] [Abstract][Full Text] [Related]
3. Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
Krawczyk A; Dirks M; Kasper M; Buch A; Dittmer U; Giebel B; Wildschütz L; Busch M; Goergens A; Schneweis KE; Eis-Hübinger AM; Sodeik B; Heiligenhaus A; Roggendorf M; Bauer D
PLoS One; 2015; 10(1):e0116800. PubMed ID: 25587898
[TBL] [Abstract][Full Text] [Related]
4. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
5. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
Rousseau A; Boutolleau D; Titier K; Bourcier T; Chiquet C; Weber M; Colin J; Gueudry J; M'Garrech M; Bodaghi B; Burrel S; Agut H; Deback C; ; Labetoulle M
Antiviral Res; 2017 Oct; 146():205-212. PubMed ID: 28939476
[TBL] [Abstract][Full Text] [Related]
6. Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.
Wasmuth S; Bauer D; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):443-51. PubMed ID: 18030487
[TBL] [Abstract][Full Text] [Related]
7. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis.
Wang X; Wang L; Wu N; Ma X; Xu J
Chin Med J (Engl); 2015 Jan; 128(1):46-50. PubMed ID: 25563312
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Activity of Oridonin Against Herpes Simplex Virus Type 1.
Jiang K; Feng J; Qi X; Ran L; Xie L
Drug Des Devel Ther; 2022; 16():4311-4323. PubMed ID: 36573068
[TBL] [Abstract][Full Text] [Related]
10. Effects of antiviral medications on herpetic epithelial keratitis in mice.
Komoto S; Higaki S; Fukuda M; Shimomura Y
Jpn J Ophthalmol; 2015 May; 59(3):194-200. PubMed ID: 25707352
[TBL] [Abstract][Full Text] [Related]
11. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
12. An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.
Park PJ; Antoine TE; Farooq AV; Valyi-Nagy T; Shukla D
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6373-81. PubMed ID: 23989188
[TBL] [Abstract][Full Text] [Related]
13. Comparison of an immortalized human corneal epithelial cell line with Vero cells in the isolation of Herpes simplex virus-1 for the laboratory diagnosis of Herpes simplex keratitis.
Athmanathan S; Reddy SB; Nutheti R; Rao GN
BMC Ophthalmol; 2002 Apr; 2():3. PubMed ID: 11983023
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir-Resistant Herpes Simplex Virus 1 Keratitis: A Concerning and Emerging Clinical Challenge.
Rousseau A; Pharm SB; Gueudry J; Deback C; Haigh O; Schweitzer C; Boutolleau D; Labetoulle M
Am J Ophthalmol; 2022 Jun; 238():110-119. PubMed ID: 35033543
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection.
Bauer D; Schmitz A; Van Rooijen N; Steuhl KP; Heiligenhaus A
Immunology; 2002 Sep; 107(1):118-28. PubMed ID: 12225370
[TBL] [Abstract][Full Text] [Related]
16. Blockade of IL-27 signaling ameliorates herpes stromal keratitis with upregulated CD4
Xia L; Tan T; Li Y; Zhong Q; Shi M
Indian J Ophthalmol; 2019 Nov; 67(11):1821-1828. PubMed ID: 31638041
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology.
Jiang Y; Yin X; Stuart PM; Leib DA
mBio; 2015 Oct; 6(6):e01426-15. PubMed ID: 26507231
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
19. Diphenyleneiodonium Treatment Inhibits the Development of Severe Herpes Stromal Keratitis Lesions.
Rana M; Setia M; Suvas PK; Chakraborty A; Suvas S
J Virol; 2022 Sep; 96(17):e0101422. PubMed ID: 35946937
[TBL] [Abstract][Full Text] [Related]
20. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
